Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;30(12):1724-1733.
doi: 10.1111/exd.14411. Epub 2021 Jun 27.

Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa

Affiliations
Review

Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa

Leonie Huitema et al. Exp Dermatol. 2021 Dec.

Abstract

Hereditary epidermolysis bullosa (EB) is a mechanobullous skin fragility disorder characterized by defective epithelial adhesion, leading to mechanical stress-induced skin blistering. Based on the level of tissue separation within the dermal-epidermal junction, EB is categorized into simplex (EBS), junctional (JEB), dystrophic (DEB) and Kindler syndrome. There is no cure for EB, and painful chronic cutaneous wounds are one of the major complications in recessive (RDEB) patients. Although RDEB is considered a cutaneous disease, recent data support the underlying systemic immunological defects. Furthermore, chronic wounds are often colonized with pathogenic microbiota, leading to excessive inflammation and altered wound healing. Consequently, patients with RDEB suffer from a painful sensation of chronic, cutaneous itching/burning and an endless battle with bacterial infections. To improve their quality of life and life expectancy, it is important to prevent cutaneous infections, dampen chronic inflammation and stimulate wound healing. A clear scientific understanding of the immunological events underlying the maintenance of chronic poorly healing wounds in RDEB patients is necessary to improve disease management and better understand other wound healing disorders. In this review, we summarize current knowledge of the role of professional phagocytes, such as neutrophils, macrophages and dendritic cells, the role of T-cell-mediated immunity in lymphoid organs, and the association of microbiota with poor wound healing in RDEB. We conclude that RDEB patients have an underlying immunity defect that seems to affect antibacterial immunity.

Keywords: cutaneous disease; epidermolysis bullosa; immunity; inflammation; microbiota; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic view of T‐cell activation in a draining lymph node after cutaneous infection. Migrating DC take up microbial antigens at the wound site and route via a lymphatic vessel to a local draining lymph node. A draining lymph node consists of micro‐domains containing paracortical T‐cell areas and follicular B‐cell areas. Lymph fluid (less than 70 kDa) enters the conduit system, which forms a tube system within T‐cell and B‐cell areas. The conduit system consists of organized collagen fibres with FRC wrapped around it. Resident DC within T‐cell areas are able to pick up antigens that flow through the conduit system. Resident mature DC present antigen to local naïve T cells, resulting in T‐cell priming and activation
FIGURE 2
FIGURE 2
Central T‐cell education in the thymus. The thymic microenvironment directs T‐cell differentiation. T cells that enter the outer cortex undergo positive selection (cTEC, cortical thymic epithelial cells). Next, T cells migrate to the inner medullary area where they undergo negative selection (mTEC, medullary thymic epithelial cells). T cells that survive all educational steps become naïve T cells and migrate to peripheral organs, such as the draining lymph nodes, mucosal barrier sites and exocrine glands
FIGURE 3
FIGURE 3
Expression of common EB‐causing gene variants in thymus and draining lymph node (cTEC, cortical thymic epithelial cell and mTEC, medullary thymic epithelial cells). (A) Thymus. (B) Draining lymph node

References

    1. van der Kooi‐Pol MM , Duipmans JC, Jonkman MF, van Dijl JM . Host‐pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus. Int J Med Microbiol. 2014;304(2):195‐203. - PubMed
    1. Has C, Nystrom A, Saeidian AH, Bruckner‐Tuderman L, Uitto J. Epidermolysis bullosa: molecular pathology of connective tissue components in the cutaneous basement membrane zone. Matrix Biol. 2018;71–72:313‐329. - PubMed
    1. Has C, South A, Uitto J. Molecular therapeutics in development for epidermolysis bullosa: update 2020. Mol Diagn Ther. 2020;24(3):299‐309. - PMC - PubMed
    1. Uitto J. Toward treatment and cure of epidermolysis bullosa. Proc Natl Acad Sci USA. 2019;116(52):26147‐26149. - PMC - PubMed
    1. Jackow J, Guo Z, Hansen C, et al. CRISPR/Cas9‐based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. Proc Natl Acad Sci USA. 2019;116(52):26846‐26852. - PMC - PubMed

Publication types

MeSH terms